產(chǎn)品名稱 | FITC標記的跨膜蛋白16A/鈣激活氯離子通道抗體 |
英文名稱 | Anti-ANO1/TMEM16A/FITC |
規(guī)格 | 100ul |
濃度 | 1mg/ml |
價格 | 來電可享受優(yōu)惠 |
英文名稱 Anti-ANO1/TMEM16A/FITC
中文名稱 :FITC標記的跨膜蛋白16A/鈣激活氯離子通道抗體
規(guī)格:100ul
說明書 100ul
研究領(lǐng)域腫瘤 細胞生物 免疫學
抗體來源Rabbit
克隆類型Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse,
產(chǎn)品應(yīng)用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分子量114kDa
細胞定位細胞膜
性 狀Lyophilized or Liquid
濃 度1mg/ml
免疫原KLH conjugated synthetic peptide derived from human DOG-1/TMEM16A
亞 型IgG
純化方法affinity purified by Protein A
儲存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Store at -20 °C for one year.
別 名 ANO 1; ANO1; ANO1_HUMAN; Anoctamin 1; Anoctamin 1 calcium activated chloride channel; Anoctamin-1; Anoctamin1; Discovered on gastrointestinal stromal tumors protein 1; DOG 1; FLJ10261; Membrane protein; Oral cancer overexpressed 2; Oral cancer overexpressed protein 2; ORAOV 2; ORAOV2; TAOS 2; TAOS2; TMEM 16A; TMEM16A; Transmembrane protein 16A (eight membrane spanning domains); Transmembrane protein 16A; Tumor amplified and overexpressed sequence 2; Tumor-amplified and overexpressed sequence 2.
